Woman and Man
- | Country :
- France
- | organs : -
- | Specialty : -
Extract
This phase I/II, multi-center study is designed to determine the pharmacokinetic profile of Raltegravir in patients with end stage liver disease and to assess drug-drug interaction when Raltegravir is combined with immunosuppressive therapy in liver transplant recipients.
Inclusion criteria
- HIV infection ,Liver Failure ,Evidence of Liver Transplantation